Cargando…
Levels of Circulating MMCN-151, a Degradation Product of Mimecan, Reflect Pathological Extracellular Matrix Remodeling in Apolipoprotein E Knockout Mice
AIM: Arterial extracellular matrix (ECM) remodeling by matrix metalloproteinases (MMPs) is one of the major hallmarks of atherosclerosis. Mimecan, also known as osteoglycin has been implicated in the integrity of the ECM. This study assessed the validity of an enzyme-linked immunosorbent assay (ELIS...
Autores principales: | Barascuk, N., Vassiliadis, E., Zheng, Q., Wang, Y., Wang, W., Larsen, L., Rasmussen, L.M., Karsdal, M.A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3201086/ https://www.ncbi.nlm.nih.gov/pubmed/22084568 http://dx.doi.org/10.4137/BMI.S7777 |
Ejemplares similares
-
The proteoglycan osteoglycin/mimecan is correlated with arteriogenesis
por: Kampmann, Andreas, et al.
Publicado: (2008) -
Biglycan fragmentation in pathologies associated with extracellular matrix remodeling by matrix metalloproteinases
por: Genovese, Federica, et al.
Publicado: (2013) -
Serum Mimecan Is Associated With Arterial Stiffness in Hypertensive Patients
por: Gu, Xiaosong, et al.
Publicado: (2015) -
Mimecan: A Newly Identified Adipokine and Regulator of Appetite
por: Page, Amanda J.
Publicado: (2015) -
Novel Cardiac-Specific Biomarkers and the Cardiovascular Continuum
por: Vassiliadis, Efstathios, et al.
Publicado: (2012)